They had the meeting in January. They were speculating they would do what they have just done in first 1/4 - it's now early second 1/4. They won't have any great influence on how long the FDA take to come back but the FDA granted them fast track already.
PAR mention they spent more previously but that would help them facilitate the next stage. The quarterly will be interesting on the spend side and cash balance. Perhaps if the 2mg is approved a deal may be more negotiable and succeed?
I'd say buying now at these levels is a good punt-wish I had waited. Less as possible diluted funding will be important. Correct, the science and results and years in the animal industry haven't changed. Sentiment and value certainly has!!
While they're waiting, they can fix up the governance side of things.
- Forums
- ASX - By Stock
- PAR
- Ann: Type D Response Submitted and Received by the US FDA
Ann: Type D Response Submitted and Received by the US FDA, page-17
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
21.0¢ |
Change
0.015(7.69%) |
Mkt cap ! $73.55M |
Open | High | Low | Value | Volume |
20.5¢ | 21.0¢ | 20.0¢ | $216.0K | 1.057M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 143324 | 20.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
21.0¢ | 44935 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 138349 | 0.200 |
9 | 191984 | 0.195 |
15 | 199884 | 0.190 |
6 | 161140 | 0.185 |
16 | 784128 | 0.180 |
Price($) | Vol. | No. |
---|---|---|
0.210 | 44935 | 3 |
0.215 | 132157 | 4 |
0.220 | 82155 | 7 |
0.225 | 31604 | 3 |
0.230 | 33834 | 4 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
EL8
ELEVATE URANIUM LTD
Murray Hill, MD & CEO
Murray Hill
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online